Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10303 |
| Vaccine Name | MV-CHIK |
| Disease Name | Chikungunya fever |
| Disease Classification | Exanthous |
| Virus Name | Chikungunya virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Live-attenuated |
| Vaccine Status | Phase 2 |
| Manufacturer | Themis Bioscience |
| Year of Manufacturing | 2021 |
| Manufacturing Country | USA |
| Age | 21 - 65 years |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | NA |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | Walter Reed Army Institute of Research |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT03807843 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT03807843 |
| Additional Links | NA |